Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichi Fukui

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
International Journal of Rheumatic Diseases|January 30, 2024
The double shared epitope: Its impact on clinical features and ultrasound findings in rheumatoid arthritisTohru Michitsuji, Shoichi Fukui, Ayako Nishino, et al.
Journal of Immunology Research|September 7, 2018
Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010Kunihiro Ichinose, Toshimasa Shimizu, Masataka Umeda, et al.
Cureus|February 17, 2025
Dynamics of Serum Cytokines and Chemokines in Patients With Idiopathic Multicentric Castleman Disease: From a Phase Ib Investigator-Initiated Trial of FilgotinibShoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, et al.
Modern Rheumatology|February 19, 2026
Long-term safety and efficacy of filgotinib in patients with idiopathic multicentric Castleman disease: 52-week results from a Phase Ib clinical trialShoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, et al.
Medicine|September 16, 2016
Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosisShoichi Fukui, Naoki Iwamoto, Masataka Umeda, et al.
Arthritis Research & Therapy|May 25, 2021
Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD)Haruki Matsumoto, Yuya Fujita, Naoki Matsuoka, et al.
International Journal of Rheumatic Diseases|November 7, 2018
Antineutrophilic cytoplasmic antibody-associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does notShoichi Fukui, Naoki Iwamoto, Ayuko Takatani, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2017
Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary NodulesChiaki Watanabe, Shoichi Fukui, Naoki Iwamoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2018
Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus ErythematosusTomohiro Koga, Tomohito Sato, Kaori Furukawa, et al.
Modern Rheumatology|September 3, 2016
Ultrasound disease activity of bilateral wrist and finger joints at three months reflects the clinical response at six months of patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugsShin-Ya Kawashiri, Ayako Nishino, Toshimasa Shimizu, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Rheumatic Diseases|January 30, 2024
The double shared epitope: Its impact on clinical features and ultrasound findings in rheumatoid arthritisTohru Michitsuji, Shoichi Fukui, Ayako Nishino, et al.
Journal of Immunology Research|September 7, 2018
Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010Kunihiro Ichinose, Toshimasa Shimizu, Masataka Umeda, et al.
Cureus|February 17, 2025
Dynamics of Serum Cytokines and Chemokines in Patients With Idiopathic Multicentric Castleman Disease: From a Phase Ib Investigator-Initiated Trial of FilgotinibShoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, et al.
Modern Rheumatology|February 19, 2026
Long-term safety and efficacy of filgotinib in patients with idiopathic multicentric Castleman disease: 52-week results from a Phase Ib clinical trialShoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, et al.
Medicine|September 16, 2016
Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosisShoichi Fukui, Naoki Iwamoto, Masataka Umeda, et al.
Arthritis Research & Therapy|May 25, 2021
Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD)Haruki Matsumoto, Yuya Fujita, Naoki Matsuoka, et al.
International Journal of Rheumatic Diseases|November 7, 2018
Antineutrophilic cytoplasmic antibody-associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does notShoichi Fukui, Naoki Iwamoto, Ayuko Takatani, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2017
Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary NodulesChiaki Watanabe, Shoichi Fukui, Naoki Iwamoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2018
Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus ErythematosusTomohiro Koga, Tomohito Sato, Kaori Furukawa, et al.
Modern Rheumatology|September 3, 2016
Ultrasound disease activity of bilateral wrist and finger joints at three months reflects the clinical response at six months of patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugsShin-Ya Kawashiri, Ayako Nishino, Toshimasa Shimizu, et al.
Pageof 13